4-butyrolactone has been researched along with Hepatitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, J; Huang, R; Lee, CH; Li, L; Li, Q; Li, S; Liu, T; Ma, K; Tian, C; Xiang, M; Xu, C; Zhang, Y | 1 |
1 other study(ies) available for 4-butyrolactone and Hepatitis
| Article | Year |
|---|---|
Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway.
Topics: 4-Butyrolactone; Animals; B7-H1 Antigen; Dendritic Cells; Forkhead Box Protein O1; Hepatitis; Inflammation; Interleukin-12; Mice; Monosaccharides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2022 |